These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 2544315)

  • 1. Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.
    Morris DD; Moore JN
    Circ Shock; 1989 Jun; 28(2):149-58. PubMed ID: 2544315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin-induced production of thromboxane and prostacyclin by equine peritoneal macrophages.
    Morris DD; Moore JN
    Circ Shock; 1987; 23(4):295-303. PubMed ID: 3121207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proadifen-induced production of prostacyclin by equine peritoneal macrophages.
    Morris DD; Moore JN; Wiltshire N; Fischer K
    Am J Vet Res; 1989 May; 50(5):747-50. PubMed ID: 2499232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin-induced procoagulant activity, eicosanoid synthesis, and tumor necrosis factor production by rat peritoneal macrophages: effect of endotoxin tolerance and glucan.
    Moore JN; Cook JA; Morris DD; Halushka PV; Wise WC
    Circ Shock; 1990 Jul; 31(3):281-95. PubMed ID: 2113440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
    J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dietary linolenic acid on endotoxin-induced thromboxane and prostacyclin production by equine peritoneal macrophages.
    Morris DD; Henry MM; Moore JN; Fischer K
    Circ Shock; 1989 Dec; 29(4):311-8. PubMed ID: 2513142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
    Giembycz MA; Kroegel C; Barnes PJ
    J Immunol; 1990 May; 144(9):3489-97. PubMed ID: 2158510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of platelet activating factor on the biosynthesis of thromboxane A2 and prostaglandin I2 in human placental villi and umbilical artery].
    Wang F; Si Y; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Apr; 32(4):202-4. PubMed ID: 9596897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages.
    Stewart AG
    Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):813-20. PubMed ID: 2558827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of immunity to core lipopolysaccharides (LPS) on the production of thromboxane and prostacyclin by equine peritoneal macrophages.
    Morris DD; Moore JN
    Cornell Vet; 1989 Jul; 79(3):231-47. PubMed ID: 2666023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
    Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
    Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia.
    Carrick JB; Morris DD; Moore JN
    Equine Vet J; 1993 Mar; 25(2):152-7. PubMed ID: 8385601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo.
    Kunievsky B; Yavin E
    J Pharmacol Exp Ther; 1992 Nov; 263(2):562-8. PubMed ID: 1432689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses.
    Menzies-Gow NJ; Sepulveda MF; Bailey SR; Cunningham FM; Elliott J
    Am J Vet Res; 2008 Feb; 69(2):199-207. PubMed ID: 18241016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism.
    Levine L
    Mol Pharmacol; 1988 Dec; 34(6):793-9. PubMed ID: 2849046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM; Moore JN; Hardee GE
    Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
    Christman BW; Lefferts PL; Blair IA; Snapper JR
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
    Shukla SD; Morrison WJ; Dhar A
    Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.